Company delivered ROE of 18.57% in year ending Mar 31, 2024 outperforming its 5 year avg. of 15.41%. (Source: Standalone Financials)
Auro Labs - Auro Laboratories Share Price
Auro Labs - Auro Labora...
Auro Labs share price insights
Company witnessed QoQ revenue decline of 52.47%, which is lowest in the last 3 years. (Source: Standalone Financials)
Stock gave a 3 year return of 27.6% as compared to Nifty Smallcap 100 which gave a return of 77.33%. (as of last trading session)
Company has spent 1.37% of its operating revenues towards interest expenses and 9.59% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
Auro Laboratories Ltd. share price moved down by -1.58% from its previous close of Rs 176.85. Auro Laboratories Ltd. stock last traded price is 174.05
Share Price Value Today/Current/Last 174.05 Previous Day 176.85
Key Metrics
PE Ratio (x) | 13.95 | ||||||||||
EPS - TTM (₹) | 12.48 | ||||||||||
MCap (₹ Cr.) | 108.48 | ||||||||||
Sectoral MCap Rank | 129 | ||||||||||
PB Ratio (x) | 2.63 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| 0.43 | ||||||||||
VWAP (₹) | 174.13 | ||||||||||
52W H/L (₹) |
Auro Labs Share Price Returns
1 Day | -1.58% |
1 Week | -2.36% |
1 Month | -1.67% |
3 Months | -19.42% |
1 Year | 115.78% |
3 Years | 34.3% |
5 Years | 201.12% |
Auro Labs News & Analysis
NewsWhat sparked the rally in small pharma stocks today
Announcement under Regulation 30 (LODR)-Newspaper Publication
AnnouncementsFinancial Results For The Quarter Ended June 30, 2024
Announcements- Announcements
Auro Labs Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Auro Labs Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Quarterly Topline Performance
Company witnessed QoQ revenue decline of 52.47%, which is lowest in the last 3 years. (Source: Standalone Financials)Employee & Interest Expense
Company has spent 1.37% of its operating revenues towards interest expenses and 9.59% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 5.92 12.46 18.40 13.73 10.55 Total Income Growth (%) -52.47 -32.28 34.03 30.17 -25.43 Total Expenses 4.67 9.94 14.17 10.65 9.30 Total Expenses Growth (%) -53.02 -29.88 32.98 14.57 -18.98 EBIT 1.26 2.53 4.23 3.08 1.25 EBIT Growth (%) -50.28 -40.32 37.64 146.46 -53.20 Profit after Tax (PAT) 0.75 2.32 2.73 1.97 0.71 PAT Growth (%) -67.57 -15.12 38.92 178.14 -60.31 EBIT Margin (%) 21.20 20.27 23.00 22.40 11.83 Net Profit Margin (%) 12.71 18.62 14.86 14.33 6.71 Basic EPS (₹) 1.21 3.72 4.39 3.16 1.14 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 85.73 55.99 54.96 41.89 32.35 Total Assets Growth (%) 53.12 1.87 31.20 29.49 -3.35 Total Liabilities 43.77 21.79 23.44 13.31 10.85 Total Liabilities Growth (%) 100.87 -7.04 76.11 22.67 -32.40 Total Equity 41.96 34.20 31.52 28.58 21.50 Total Equity Growth (%) 22.69 8.50 10.29 32.93 23.49 Current Ratio (x) 1.29 1.97 1.87 3.32 2.93 Total Debt to Equity (x) 0.63 0.18 0.03 0.07 0.08 Contingent Liabilities 3.69 4.45 3.15 5.96 2.89 All figures in Rs Cr, unless mentioned otherwise
Insights
Increase in Cash from Investing
Company has used Rs 38.67 cr for investing activities which is an YoY increase of 661.03%. (Source: Standalone Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 18.81 3.28 -6.59 5.80 9.19 Net Cash used in Investing Activities -38.67 -5.08 -5.34 3.51 -2.21 Net Cash flow from Financing Activities 19.09 -8.18 9.79 -0.46 -5.40 Net Cash Flow -0.77 -9.98 -2.14 8.85 1.58 Closing Cash & Cash Equivalent 1.65 2.42 12.40 14.54 5.68 Closing Cash & Cash Equivalent Growth (%) -31.78 -80.50 -14.73 155.73 38.38 Total Debt/ CFO (x) 1.40 1.88 -0.13 0.35 0.20 All figures in Rs Cr, unless mentioned otherwise
Insights
ROE Outperforming 5 Year Average
Company delivered ROE of 18.57% in year ending Mar 31, 2024 outperforming its 5 year avg. of 15.41%. (Source: Standalone Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 18.57 7.14 9.02 25.11 18.86 Return on Capital Employed (%) 17.93 11.25 13.49 32.80 23.30 Return on Assets (%) 9.08 4.36 5.17 17.13 12.53 Interest Coverage Ratio (x) 16.55 6.55 6.92 23.92 13.10 Asset Turnover Ratio (x) 0.76 0.95 1.05 129.50 135.37 Price to Earnings (x) 12.90 13.95 21.98 7.04 4.84 Price to Book (x) 2.39 1.00 1.98 1.77 0.91 EV/EBITDA (x) 10.27 7.09 8.91 3.17 2.21 EBITDA Margin (%) 22.69 10.08 11.24 22.11 16.28
Auro Labs Peer Comparison
Auro Labs Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 27.6% as compared to Nifty Smallcap 100 which gave a return of 77.33%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 27.6% return as compared to Nifty Pharma which gave investors 56.68% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 27.6% as compared to Nifty Smallcap 100 which gave a return of 77.33%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 27.6% return as compared to Nifty Pharma which gave investors 56.68% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Auro Labs Board Meeting/AGM
Auro Labs Dividends
- Others
Board Meeting/AGM details are not available.
Dividend announcements are not available.
No other corporate actions details are available.
About Auro Labs
Auro Laboratories Ltd., incorporated in the year 1989, is a Small Cap company (having a market cap of Rs 108.48 Crore) operating in Pharmaceuticals sector. Auro Laboratories Ltd. key Products/Revenue Segments include Metformin Hydrochloride, Export Incentives for the year ending 31-Mar-2023. Show More
Executives
Auditors
- SD
Sharat Deorah
Chairman & Managing DirectorKSKiran Suresh Kulkarni
Whole Time DirectorSDSiddhartha Deorah
Whole Time DirectorKVKavita Vijayakant Sharma
Ind. Non-Executive DirectorShow More - Kothari Jain & AssociatesKhurdia Jain & Co.
Industry
Key Indices Listed on
-
Address
K-56, M.I.D.C. Industrial Area,Tarapur, Boisar,Palghar District, Maharashtra - 401506
More Details
FAQs about Auro Labs share
- 1. What is Auro Labs share price and what are the returns for Auro Labs share?As on 16 Aug, 2024, 03:56 PM IST Auro Labs share price was down by 1.58% basis the previous closing price of Rs 178.65. Auro Labs share price was Rs 174.05.
- 2. Who owns Auro Labs?
- Promoter holding has gone up from 52.09 (30 Sep 2023) to 52.15 (30 Jun 2024)
- Domestic Institutional Investors holding has not changed in last 9 months and holds 0.01 stake as on 30 Jun 2024
- Other investor holding have gone down from 47.9 (30 Sep 2023) to 47.84 (30 Jun 2024)
- 3. Who are the peers for Auro Labs in Pharmaceuticals sector?Top 10 Peers for Auro Labs are Parnax Lab Ltd., Everest Organics Ltd., Mercury Laboratories Ltd., Source Natural Foods & Herbal Supplements Ltd., Madhuveer Com 18 Network Ltd., Biofil Chemicals & Pharmaceuticals Ltd., Samrat Pharmachem Ltd., Aayush Wellness Ltd., Makers Laboratories Ltd. and Bharat Immunological & Biologicals Corporation Ltd.
- 4. What are the Auro Labs quarterly results?Total Revenue and Earning for Auro Labs for the year ending 2024-03-31 was Rs 55.14 Cr and Rs 7.79 Cr on Standalone basis. Last Quarter 2024-06-30, Auro Labs reported an income of Rs 5.92 Cr and profit of Rs 0.75 Cr.
- 5. What's the market capitalization of Auro Labs?Auro Labs share has a market capitalization of Rs 108.48 Cr. Within Pharmaceuticals sector, it's market cap rank is 129.
- 6. Who's the chairman of Auro Labs?Sharat Deorah is the Chairman & Managing Director of Auro Labs
- 7. What are the key metrics to analyse Auro Labs Share Price?Auro Labs share can be quickly analyzed on following metrics:
- Stock's PE is 13.95
- Price to Book Ratio of 2.63
- 8. What dividend is Auro Labs giving?No dividend has been report for Auro Laboratories Ltd..
- 9. What is the PE & PB ratio of Auro Labs?The PE ratio of Auro Labs stands at 14.18, while the PB ratio is 2.63.
- 10. What has been highest price of Auro Labs share in last 52 weeks?Auro Labs share price saw a 52 week high of Rs 307.20 and 52 week low of Rs 76.19.
- 11. What is the CAGR of Auro Labs?The CAGR of Auro Labs is -0.29.
Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.